Search Results - "Parker, Brittany"

Refine Results
  1. 1
  2. 2

    Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas by Lang, Frederick M, Hossain, Anwar, Gumin, Joy, Momin, Eric N, Shimizu, Yuzaburo, Ledbetter, Dan, Shahar, Tal, Yamashita, Shinji, Parker Kerrigan, Brittany, Fueyo, Juan, Sawaya, Raymond, Lang, Frederick F

    Published in Neuro-oncology (Charlottesville, Va.) (19-02-2018)
    “…MicroRNAs (miRs) are promising new therapeutics for glioblastoma. However, which miRs are most effective against glioblastomas and how these miRs should be…”
    Get full text
    Journal Article
  3. 3

    Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours by Parker, Brittany C, Engels, Manon, Annala, Matti, Zhang, Wei

    Published in The Journal of pathology (01-01-2014)
    “…The emergence of fibroblast growth factor receptor (FGFR) family fusions across diverse cancers has brought attention to FGFR‐derived cancer therapies. The…”
    Get full text
    Journal Article
  4. 4

    MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer by Liu, Guoyan, Sun, Yan, Ji, Ping, Li, Xia, Cogdell, David, Yang, Da, Parker Kerrigan, Brittany C, Shmulevich, Ilya, Chen, Kexin, Sood, Anil K, Xue, Fengxia, Zhang, Wei

    Published in The Journal of pathology (01-07-2014)
    “…Ovarian carcinoma is the most lethal gynaecological malignancy. Better understanding of the molecular pathogenesis of this disease and effective targeted…”
    Get full text
    Journal Article
  5. 5

    Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions by Guo, Fei, Parker Kerrigan, Brittany C, Yang, Da, Hu, Limei, Shmulevich, Ilya, Sood, Anil K, Xue, Fengxia, Zhang, Wei

    Published in Journal of hematology and oncology (05-03-2014)
    “…Epithelial-to-mesenchymal transition (EMT) and its reverse process, mesenchymal-to-epithelial transition (MET), play important roles in embryogenesis, stem…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas by Parker Kerrigan, Brittany C, Shimizu, Yuzaburo, Andreeff, Michael, Lang, Frederick F

    Published in Cytotherapy (Oxford, England) (01-04-2017)
    “…Abstract Mesenchymal stromal cells (MSCs) are a type of adult stem cell that has been exploited for the treatment of a variety of diseases, including cancer…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Parental Grief, Wrongful Incarceration, and the Continued Effects after Exoneration by Temares, Amanda E., Parker, Brittany D., Walker, Lenore E., Shapiro, David

    “…The current article was motivated by a case study to diversify present literature on parental grief and wrongful conviction. The authors sought to accomplish…”
    Get full text
    Journal Article
  10. 10

    Ionizing radiation augments glioma tropism of mesenchymal stem cells by Thomas, Jonathan G, Parker Kerrigan, Brittany C, Hossain, Anwar, Gumin, Joy, Shinojima, Naoki, Nwajei, Felix, Ezhilarasan, Ravesanker, Love, Patrice, Sulman, Erik P, Lang, Frederick F

    Published in Journal of neurosurgery (01-01-2018)
    “…OBJECTIVE Mesenchymal stem cells (MSCs) have been shown to localize to gliomas after intravascular delivery. Because these cells home to areas of tissue…”
    Get full text
    Journal Article
  11. 11

    HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion by Li, Tao, Mehraein-Ghomi, Farideh, Forbes, M. Elizabeth, Namjoshi, Sanjeev V., Ballard, E. Ashley, Song, Qianqian, Chou, Ping-Chieh, Wang, Xuya, Parker Kerrigan, Brittany C., Lang, Frederick F., Lesser, Glenn, Debinski, Waldemar, Yang, Xuejun, Zhang, Wei

    Published in Molecular therapy (06-04-2022)
    “…The FGFR3-TACC3 (F3-T3) fusion gene was discovered as an oncogenic molecule in glioblastoma and bladder cancers, and has subsequently been found in many cancer…”
    Get full text
    Journal Article
  12. 12

    Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells by Srinivasan, Visish M, Gumin, Joy, Camstra, Kevin M, Chen, Stephen R, Johnson, Jeremiah N, Shimizu, Yuzaburo, Parker Kerrigan, Brittany C, Shpall, Elizabeth J, Lang, Frederick F, Kan, Peter

    Published in Journal of neurosurgery (01-10-2020)
    “…Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) have been used in clinical trials for the treatment of several neurological disorders. MSCs have…”
    Get full text
    Journal Article
  13. 13

    Tumor Vaccines for Malignant Gliomas by Srinivasan, Visish M., Ferguson, Sherise D., Lee, Sungho, Weathers, Shiao-Pei, Kerrigan, Brittany C. Parker, Heimberger, Amy B.

    Published in Neurotherapeutics (01-04-2017)
    “…Despite continued research efforts, glioblastoma multiforme (GBM) remains the deadliest brain tumor. Immunotherapy offers a novel way to treat this disease,…”
    Get full text
    Journal Article Book Review
  14. 14
  15. 15

    Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model by Srinivasan, Visish M, Gumin, Joy, Camstra, Kevin M, Collins, Dalis E, Chen, Melissa M, Shpall, Elizabeth J, Parker Kerrigan, Brittany C, Johnson, Jeremiah N, Chen, Stephen R, Fueyo, Juan, Gomez-Manzano, Cande, Lang, Frederick F, Kan, Peter

    Published in Neurosurgery (01-01-2021)
    “…Abstract BACKGROUND Delta-24-RGD, an oncolytic adenovirus, shows promise against glioblastoma. To enhance virus delivery, we recently demonstrated that human…”
    Get full text
    Journal Article
  16. 16

    Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress by Yang, Ping, Baciu, Peter, Kerrigan, Brittany C Parker, Etheridge, Menna, Sung, Eric, Toimil, Brett A, Berchuck, Jacob E, Jaffe, Glenn J

    “…Retinal pigment epithelial (RPE) cell death is an important feature of the advanced forms of AMD. Complement alternative pathway (AP) activation is associated…”
    Get full text
    Journal Article
  17. 17

    Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination by Grier, Mark D, West, Kathryn L, Kelm, Nathaniel D, Fu, Cary, Does, Mark D, Parker, Brittany, McBrier, Eleanor, Lagrange, Andre H, Ess, Kevin C, Carson, Robert P

    Published in PloS one (21-11-2017)
    “…Myelin abnormalities are increasingly being recognized as an important component of a number of neurologic developmental disorders. The integration of many…”
    Get full text
    Journal Article
  18. 18

    Targeting the Tumor Microenvironment in Brain Metastasis by Giridharan, Nisha, Glitza Oliva, Isabella C., O’Brien, Barbara J., Parker Kerrigan, Brittany C., Heimberger, Amy B., Ferguson, Sherise D.

    Published in Neurosurgery clinics of North America (01-10-2020)
    “…Dynamic interplay between cancer cells and the surrounding microenvironment is a feature of the metastatic process. Successful metastatic brain colonization…”
    Get full text
    Journal Article
  19. 19
  20. 20

    RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine by Parker Kerrigan, Brittany C, Ledbetter, Daniel, Kronowitz, Matthew, Phillips, Lynette, Gumin, Joy, Hossain, Anwar, Yang, Jing, Mendt, Mayela, Singh, Sanjay, Cogdell, David, Ene, Chibawanye, Shpall, Elizabeth, Lang, Frederick F

    Published in Neuro-oncology advances (01-01-2020)
    “…Abstract Background Fusion genes form as a result of abnormal chromosomal rearrangements linking previously separate genes into one transcript. The FGFR3-TACC3…”
    Get full text
    Journal Article